XML 78 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities      
Net income $ 462 $ 1,034 $ 1,339
Adjustments to reconcile net income to net cash provided by operating activities      
Depreciation and amortization 713 641 601
Stock-based compensation expense 25 22 23
Loss from disposition and write-off of property, plant and equipment 49 44 22
Deferred income taxes 54 62 (534)
Other losses (gains), net 1 (20) (3)
Changes in operating assets and liabilities, net of effect of business acquisitions      
Accounts receivable 59 (58) (40)
Inventories 112 (123) (32)
Prepaid expenses and other current assets (1) (1) 26
Accounts payable (89) (100) 86
Accrued and other liabilities (13) (8) 115
Other, net (71) (84) (75)
Net cash provided by operating activities 1,301 1,409 1,528
Cash flows from investing activities      
Acquisition of businesses, net of cash acquired (314) 0 (13)
Additions to property, plant and equipment (787) (702) (577)
Additions to investments in unconsolidated subsidiaries (862) (68) (66)
Other, net 9 16 4
Net cash used for investing activities (1,954) (754) (652)
Cash flows from financing activities      
Dividends paid (132) (120) (103)
Distributions to noncontrolling interests (50) (45) (28)
Proceeds from Issuance of Debt 784 0 0
Proceeds from notes payable 20 14 978
Net proceeds from issuance of Westlake Chemical Partners LP common units 63 0 111
Repayment of term loan 0 0 (150)
Repayment of revolver 0 0 (550)
Redemption and repayment of notes payable (18) (1,179) (257)
Repurchase of common stock for treasury (30) (106) 0
Other (7) 9 5
Net cash provided by (used for) financing activities 630 (1,427) 6
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2) (7) 26
Net increase (decrease) in cash, cash equivalents and restricted cash (25) (779) 908
Cash, cash equivalents and restricted cash at beginning of the year 775 1,554 646
Cash, cash equivalents and restricted cash at end of the year $ 750 $ 775 $ 1,554